A-802715

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameA-802715
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor inhibitorsCytokines inhibitorsT lymphocytes inhibitors
TargetsCytokinesTumor necrosis factor
Therapy Area/IndicationsRejection of organ transplantationShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A